HHS Memos, 5 Senate Bills Target Drug Prices And Tactics
The Biden administration outlined its enforcement vision Thursday for drug pricing rebates potentially worth tens of billions of dollars, and U.S. senators trained bipartisan fire on longstanding concerns about patent and...To view the full article, register now.
Already a subscriber? Click here to view full article